Premium
Using GWAS top hits to inform priors in Bayesian fine‐mapping association studies
Author(s) -
Walters Kevin,
Cox Angela,
Yaacob Hannuun
Publication year - 2019
Publication title -
genetic epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.301
H-Index - 98
eISSN - 1098-2272
pISSN - 0741-0395
DOI - 10.1002/gepi.22212
Subject(s) - prior probability , bayes' theorem , genome wide association study , bayesian probability , computer science , genetic association , single nucleotide polymorphism , bayes factor , snp , statistics , econometrics , computational biology , mathematics , artificial intelligence , biology , genetics , genotype , gene
The default causal single‐nucleotide polymorphism (SNP) effect size prior in Bayesian fine‐mapping studies is usually the Normal distribution. This choice is often based on computational convenience, rather than evidence that it is the most suitable prior distribution. The choice of prior is important because previous studies have shown considerable sensitivity of causal SNP Bayes factors to the form of the prior. In some well‐studied diseases there are now considerable numbers of genome‐wide association study (GWAS) top hits along with estimates of the number of yet‐to‐be‐discovered causal SNPs. We show how the effect sizes of the top hits and estimates of the number of yet‐to‐be‐discovered causal SNPs can be used to choose between the Laplace and Normal priors, to estimate the prior parameters and to quantify the uncertainty in this estimation. The methodology can readily be applied to other priors. We show that the top hits available from breast cancer GWAS provide overwhelming support for the Laplace over the Normal prior, which has important consequences for variant prioritisation. This work in this paper enables practitioners to derive more objective priors than are currently being used and could lead to prioritisation of different variants.